Jump to main content
Jump to site search


The blood copper isotopic composition is a prognostic indicator of the hepatic injury in Wilson disease

Author affiliations

Abstract

Wilson disease (WD) is an autosomal recessive disorder of copper (Cu) metabolism. The gene responsible for WD, ATP7B, is involved in the cellular transport of Cu, and mutations in the ATP7B gene induce accumulation of Cu in the liver and ultimately in the brain. In a pilot study, the natural variations of copper stable isotope ratios (65Cu/63Cu) in the serum of WD patients have been shown to differ from that of healthy controls. In the present study, we challenged these first results by measuring the 65Cu/63Cu ratios in the blood of treated (n = 25), naïve patients (n = 11) and age matched healthy controls (n = 75). The results show that naïve patients and healthy controls exhibit undistinguishable 65Cu/63Cu ratios, implying that the Cu isotopic ratio cannot serve as a reliable diagnostic biomarker. The type of treatment (D-penicillamine vs. triethylenetetramine) does not affect the 65Cu/63Cu ratios in WD patients, which remain constant regardless of the type and duration of the treatment. In addition, the 65Cu/63Cu ratios do not vary in naïve patients after the onset of the treatment. However, the 65Cu/63Cu ratios decrease with the degree of liver fibrosis and the gradient of the phenotypic presentation, i.e. presymptomatic, hepatic and neurologic. To get insights into the mechanisms at work, we study the effects of the progress of the WD on the organism by measuring the Cu concentrations and the 65Cu/63Cu ratios in the liver, feces and plasma of 12 and 45 week old Atp7b−/− mice. The evolution of the 65Cu/63Cu ratios is marked by a decrease in all tissues. The results show that 63Cu accumulates in the liver preferentially to 65Cu due to the preferential cellular entry of 63Cu and the impairment of the 63Cu exit by ceruloplasmin. The hepatic accumulation of monovalent 63Cu+ is likely to fuel the production of free radicals, which is potentially an explanation of the pathogenicity of WD. Altogether, the results suggest that the blood 65Cu/63Cu ratio recapitulates WD progression and is a potential prognostic biomarker of WD.

Graphical abstract: The blood copper isotopic composition is a prognostic indicator of the hepatic injury in Wilson disease

Back to tab navigation

Article information


Submitted
17 Jul 2020
Accepted
16 Sep 2020
First published
17 Sep 2020

Metallomics, 2020, Advance Article
Article type
Paper

The blood copper isotopic composition is a prognostic indicator of the hepatic injury in Wilson disease

A. Lamboux, E. Couchonnal-Bedoya, O. Guillaud, C. Laurencin, L. Lion-François, A. Belmalih, E. Mintz, V. Brun, M. Bost, A. Lachaux and V. Balter, Metallomics, 2020, Advance Article , DOI: 10.1039/D0MT00167H

Social activity

Search articles by author

Spotlight

Advertisements